JNJ
Johnson & Johnson·NYSE
--
--(--)
--
--(--)
JNJ fundamentals
Johnson & Johnson (JNJ) Revenue Breakdown: Q4 2025 Business & Regional Performance
Johnson & Johnson (JNJ) reported total revenue of 24.56B USD in Q4 2025, with its core business segment Innovative Medicine contributing 64.17%. Regionally, United States remained the largest market, accounting for 57.79% of total revenue. Explore Johnson & Johnson's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Johnson & Johnson (JNJ) reported total revenue of 24.56B USD in Q4 2025, with its core business segment Innovative Medicine contributing 64.17%. Regionally, United States remained the largest market, accounting for 57.79% of total revenue. Explore Johnson & Johnson's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Johnson & Johnson next quarter?What is Johnson & Johnson's latest dividend and current dividend yield?What were the key takeaways from Johnson & Johnson's earnings call?What is the revenue and EPS growth rate for Johnson & Johnson year over year?What does Johnson & Johnson do and what are its main business segments?Did Johnson & Johnson beat or miss consensus estimates last quarter?What were the key takeaways from Johnson & Johnson’s earnings call?What factors drove the changes in Johnson & Johnson's revenue and profit?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
